- Home
- PROF vs DMB Comparison
PROF vs DMB Comparison
Compare PROF & DMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROF
- DMB
- Stock Information
- Founded
- PROF N/A
- DMB 2013
- Country
- PROF Canada
- DMB United States
- Employees
- PROF N/A
- DMB N/A
- Industry
- PROF Medical/Dental Instruments
- DMB Trusts Except Educational Religious and Charitable
- Sector
- PROF Health Care
- DMB Finance
- Exchange
- PROF Nasdaq
- DMB Nasdaq
- Market Cap
- PROF 179.7M
- DMB 196.9M
- IPO Year
- PROF N/A
- DMB N/A
- Fundamental
- Price
- PROF $6.55
- DMB $10.55
- Analyst Decision
- PROF Strong Buy
- DMB
- Analyst Count
- PROF 1
- DMB 0
- Target Price
- PROF $11.00
- DMB N/A
- AVG Volume (30 Days)
- PROF 91.5K
- DMB 76.6K
- Earning Date
- PROF 11-13-2025
- DMB 01-01-0001
- Dividend Yield
- PROF N/A
- DMB 4.17%
- EPS Growth
- PROF N/A
- DMB N/A
- EPS
- PROF N/A
- DMB N/A
- Revenue
- PROF $14,297,000.00
- DMB N/A
- Revenue This Year
- PROF $60.07
- DMB N/A
- Revenue Next Year
- PROF $120.03
- DMB N/A
- P/E Ratio
- PROF N/A
- DMB N/A
- Revenue Growth
- PROF 67.94
- DMB N/A
- 52 Week Low
- PROF $3.76
- DMB $8.94
- 52 Week High
- PROF $8.75
- DMB $11.79
- Technical
- Relative Strength Index (RSI)
- PROF 59.07
- DMB 38.57
- Support Level
- PROF $5.74
- DMB $10.73
- Resistance Level
- PROF $6.99
- DMB $10.61
- Average True Range (ATR)
- PROF 0.50
- DMB 0.10
- MACD
- PROF -0.01
- DMB -0.04
- Stochastic Oscillator
- PROF 62.60
- DMB 12.50
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
About DMB BNY Mellon Municipal Bond Infrastructure Fund Inc.
BNY Mellon Municipal Bond Infrastructure Fund, Inc. is a diversified closed-end management investment company. The fund's investment objective is to provide as high a current income exempt from regular federal income tax as is consistent with the preservation of capital. It invests in transportation, energy and utilities, social infrastructure, and water and environmental sectors.